Share Price and Basic Stock Data
Last Updated: November 6, 2025, 11:05 am
| PEG Ratio | 4.73 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
ARCL Organics Ltd operates within the chemicals sector, focusing on organic chemicals. As of the latest reporting, the company’s stock price stood at ₹320, with a market capitalization of ₹256 Cr. The company reported total sales of ₹165 Cr for the fiscal year ending March 2023, reflecting a steady increase from ₹141 Cr in the previous year. The revenue trajectory appears positive, with sales projected to rise to ₹191 Cr in FY 2024 and ₹251 Cr in FY 2025, indicating a compound annual growth rate (CAGR) of approximately 24.5% over the two-year period. Quarterly sales demonstrate some fluctuations; for instance, the company achieved ₹46.44 Cr in March 2023 and ₹59.93 Cr in June 2024. However, recent quarters indicate resilience, with reported sales of ₹48.33 Cr in December 2023 and ₹57.57 Cr in March 2025, suggesting a recovery post-pandemic and a rebound in demand within the organic chemicals sector.
Profitability and Efficiency Metrics
ARCL Organics reported a net profit of ₹13 Cr for the fiscal year ending March 2023, with a profit margin of approximately 7.07%. The profit margins have shown variability, with an operating profit margin (OPM) recorded at 11% for the same year. The company’s return on equity (ROE) stood at 16.8%, indicating effective utilization of shareholders’ funds. Efficiency metrics like the cash conversion cycle (CCC) are also noteworthy; the CCC was reported at 28 days, which is relatively low compared to industry averages, suggesting efficient management of working capital. The interest coverage ratio (ICR) was strong at 6.23x, demonstrating the company’s ability to meet its interest obligations comfortably. However, the company’s operating profit margins have shown a declining trend, falling to 9% in FY 2025 from 11% in FY 2022, indicating potential cost pressures or pricing challenges that need to be addressed.
Balance Sheet Strength and Financial Ratios
As of March 2025, ARCL Organics reported total assets of ₹161 Cr, with equity capital fixed at ₹8 Cr and reserves amounting to ₹68 Cr. The company’s borrowings had increased to ₹35 Cr, indicating a leverage ratio of 0.43x, which is within manageable limits compared to sector norms. The price-to-book value ratio (P/BV) stood at 2.37x, suggesting that the stock is valued at a premium relative to its book value, which reflects investor confidence in future growth potential. The return on capital employed (ROCE) was reported at 20.4%, demonstrating efficient use of capital to generate profits. However, the increase in borrowings raises concerns regarding potential liquidity risks, especially in light of the company’s declining operating profit margins. The overall financial health remains robust, but vigilance is warranted as the company navigates an evolving market landscape.
Shareholding Pattern and Investor Confidence
The shareholding pattern of ARCL Organics reflects a significant level of promoter confidence, with promoters holding 69.22% of the shares as of September 2023. This level of promoter ownership is conducive to stability and long-term strategic alignment. Institutional participation is minimal, with domestic institutional investors (DIIs) holding only 0.75% of the shares, while foreign institutional investors (FIIs) have no reported stake. The public shareholding accounts for 30.02%, with a total of 7,841 shareholders as of June 2025. The increase in the number of shareholders from 6,663 in September 2023 indicates growing interest in the stock, which could be a positive signal for future capital raising or market support. However, the lack of institutional investor confidence may pose risks in terms of liquidity and market sentiment, especially during volatility.
Outlook, Risks, and Final Insight
ARCL Organics has demonstrated a solid growth trajectory in revenue and profitability metrics, bolstered by strong operational efficiency. However, the company faces several risks, including rising input costs, which could further compress operating margins, and its relatively high leverage, which could strain liquidity in adverse market conditions. The dependence on promoter ownership without significant institutional backing may limit stock liquidity and increase volatility. Conversely, the company’s robust ROE and ROCE suggest effective capital management and a potential for sustained profitability. Moving forward, ARCL Organics must focus on cost management strategies and possibly explore avenues to attract institutional investors to enhance financial stability and market confidence. The company’s ability to navigate these risks while capitalizing on growth opportunities in the organic chemicals sector will be crucial for its future performance.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of ARCL Organics Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 131 Cr. | 366 | 458/255 | 135 | 390 | 0.03 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 7,973 Cr. | 10,057 | 14,284/8,150 | 57.7 | 1,177 | 0.08 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 37.5 Cr. | 125 | 329/114 | 15.1 | 24.9 | 0.80 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 35.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 264 Cr. | 330 | 385/163 | 20.4 | 94.6 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,403.86 Cr | 1,681.73 | 402.50 | 327.84 | 0.37% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 41.00 | 31.71 | 46.44 | 41.58 | 43.25 | 48.33 | 57.57 | 59.93 | 56.46 | 61.96 | 72.24 | 67.34 |
| Expenses | 36.27 | 30.36 | 40.04 | 38.47 | 39.51 | 41.00 | 52.20 | 54.12 | 51.33 | 58.14 | 63.25 | 60.94 |
| Operating Profit | 4.73 | 1.35 | 6.40 | 3.11 | 3.74 | 7.33 | 5.37 | 5.81 | 5.13 | 3.82 | 8.99 | 6.40 |
| OPM % | 11.54% | 4.26% | 13.78% | 7.48% | 8.65% | 15.17% | 9.33% | 9.69% | 9.09% | 6.17% | 12.44% | 9.50% |
| Other Income | 0.58 | 0.01 | 2.25 | 0.43 | 0.64 | 0.81 | 0.82 | 0.41 | 0.71 | 0.83 | 0.40 | 0.83 |
| Interest | 0.44 | 0.45 | 0.51 | 0.51 | 1.03 | 1.85 | 0.76 | 1.25 | 1.23 | 1.14 | 1.24 | 1.17 |
| Depreciation | 1.00 | 0.64 | 1.30 | 1.33 | 1.29 | 1.17 | 0.50 | 1.37 | 1.13 | 1.29 | 1.42 | 1.39 |
| Profit before tax | 3.87 | 0.27 | 6.84 | 1.70 | 2.06 | 5.12 | 4.93 | 3.60 | 3.48 | 2.22 | 6.73 | 4.67 |
| Tax % | 28.94% | 29.63% | 73.39% | 16.47% | 55.83% | 30.86% | 2.03% | 27.22% | 42.53% | 24.77% | 19.02% | 18.42% |
| Net Profit | 2.76 | 0.19 | 1.81 | 1.42 | 0.91 | 3.53 | 4.83 | 2.62 | 2.01 | 1.67 | 5.46 | 3.81 |
| EPS in Rs | 3.45 | 0.24 | 2.26 | 1.78 | 1.14 | 4.41 | 6.04 | 3.28 | 2.51 | 2.09 | 6.82 | 4.76 |
Last Updated: August 19, 2025, 11:30 pm
Below is a detailed analysis of the quarterly data for ARCL Organics Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 67.34 Cr.. The value appears to be declining and may need further review. It has decreased from 72.24 Cr. (Mar 2025) to 67.34 Cr., marking a decrease of 4.90 Cr..
- For Expenses, as of Jun 2025, the value is 60.94 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 63.25 Cr. (Mar 2025) to 60.94 Cr., marking a decrease of 2.31 Cr..
- For Operating Profit, as of Jun 2025, the value is 6.40 Cr.. The value appears to be declining and may need further review. It has decreased from 8.99 Cr. (Mar 2025) to 6.40 Cr., marking a decrease of 2.59 Cr..
- For OPM %, as of Jun 2025, the value is 9.50%. The value appears to be declining and may need further review. It has decreased from 12.44% (Mar 2025) to 9.50%, marking a decrease of 2.94%.
- For Other Income, as of Jun 2025, the value is 0.83 Cr.. The value appears strong and on an upward trend. It has increased from 0.40 Cr. (Mar 2025) to 0.83 Cr., marking an increase of 0.43 Cr..
- For Interest, as of Jun 2025, the value is 1.17 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.24 Cr. (Mar 2025) to 1.17 Cr., marking a decrease of 0.07 Cr..
- For Depreciation, as of Jun 2025, the value is 1.39 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.42 Cr. (Mar 2025) to 1.39 Cr., marking a decrease of 0.03 Cr..
- For Profit before tax, as of Jun 2025, the value is 4.67 Cr.. The value appears to be declining and may need further review. It has decreased from 6.73 Cr. (Mar 2025) to 4.67 Cr., marking a decrease of 2.06 Cr..
- For Tax %, as of Jun 2025, the value is 18.42%. The value appears to be improving (decreasing) as expected. It has decreased from 19.02% (Mar 2025) to 18.42%, marking a decrease of 0.60%.
- For Net Profit, as of Jun 2025, the value is 3.81 Cr.. The value appears to be declining and may need further review. It has decreased from 5.46 Cr. (Mar 2025) to 3.81 Cr., marking a decrease of 1.65 Cr..
- For EPS in Rs, as of Jun 2025, the value is 4.76. The value appears to be declining and may need further review. It has decreased from 6.82 (Mar 2025) to 4.76, marking a decrease of 2.06.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 16, 2025, 1:38 pm
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 49 | 71 | 71 | 87 | 141 | 165 | 191 | 251 | 258 |
| Expenses | 46 | 67 | 64 | 74 | 126 | 147 | 171 | 227 | 234 |
| Operating Profit | 2 | 4 | 7 | 12 | 15 | 18 | 20 | 24 | 24 |
| OPM % | 5% | 6% | 10% | 14% | 11% | 11% | 10% | 9% | 9% |
| Other Income | 2 | 1 | 1 | 1 | 2 | 3 | 3 | 2 | 3 |
| Interest | 2 | 2 | 3 | 2 | 2 | 2 | 4 | 5 | 5 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 3 | 4 | 5 | 5 |
| Profit before tax | 1 | 2 | 3 | 10 | 15 | 17 | 14 | 16 | 17 |
| Tax % | 45% | 26% | 24% | 29% | 29% | 30% | 23% | 27% | |
| Net Profit | 1 | 1 | 3 | 7 | 10 | 12 | 11 | 12 | 13 |
| EPS in Rs | 0.70 | 1.40 | 3.21 | 9.14 | 13.10 | 14.72 | 13.38 | 14.69 | 16.18 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | 200.00% | 133.33% | 42.86% | 20.00% | -8.33% | 9.09% |
| Change in YoY Net Profit Growth (%) | 0.00% | 200.00% | -66.67% | -90.48% | -22.86% | -28.33% | 17.42% |
ARCL Organics Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2018-2019 to 2024-2025.
Growth
Last Updated: September 5, 2025, 2:21 pm
Balance Sheet
Last Updated: July 25, 2025, 1:51 pm
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves | 13 | 14 | 16 | 24 | 34 | 46 | 56 | 68 |
| Borrowings | 10 | 20 | 17 | 10 | 16 | 20 | 29 | 35 |
| Other Liabilities | 18 | 15 | 13 | 26 | 35 | 39 | 55 | 50 |
| Total Liabilities | 49 | 57 | 55 | 67 | 93 | 113 | 148 | 161 |
| Fixed Assets | 18 | 21 | 20 | 20 | 26 | 45 | 62 | 67 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Other Assets | 30 | 35 | 33 | 47 | 66 | 66 | 85 | 93 |
| Total Assets | 49 | 57 | 55 | 67 | 93 | 113 | 148 | 161 |
Below is a detailed analysis of the balance sheet data for ARCL Organics Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 8.00 Cr..
- For Reserves, as of Mar 2025, the value is 68.00 Cr.. The value appears strong and on an upward trend. It has increased from 56.00 Cr. (Mar 2024) to 68.00 Cr., marking an increase of 12.00 Cr..
- For Borrowings, as of Mar 2025, the value is 35.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 29.00 Cr. (Mar 2024) to 35.00 Cr., marking an increase of 6.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 50.00 Cr.. The value appears to be improving (decreasing). It has decreased from 55.00 Cr. (Mar 2024) to 50.00 Cr., marking a decrease of 5.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 161.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 148.00 Cr. (Mar 2024) to 161.00 Cr., marking an increase of 13.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 67.00 Cr.. The value appears strong and on an upward trend. It has increased from 62.00 Cr. (Mar 2024) to 67.00 Cr., marking an increase of 5.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1.00 Cr..
- For Other Assets, as of Mar 2025, the value is 93.00 Cr.. The value appears strong and on an upward trend. It has increased from 85.00 Cr. (Mar 2024) to 93.00 Cr., marking an increase of 8.00 Cr..
- For Total Assets, as of Mar 2025, the value is 161.00 Cr.. The value appears strong and on an upward trend. It has increased from 148.00 Cr. (Mar 2024) to 161.00 Cr., marking an increase of 13.00 Cr..
Notably, the Reserves (68.00 Cr.) exceed the Borrowings (35.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -8.00 | -16.00 | -10.00 | 2.00 | -1.00 | -2.00 | -9.00 | -11.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 97 | 87 | 87 | 96 | 82 | 71 | 65 | 75 |
| Inventory Days | 59 | 35 | 45 | 40 | 43 | 38 | 58 | 28 |
| Days Payable | 102 | 51 | 43 | 89 | 88 | 83 | 110 | 75 |
| Cash Conversion Cycle | 55 | 71 | 89 | 48 | 37 | 25 | 13 | 28 |
| Working Capital Days | 56 | 84 | 32 | 49 | 46 | 31 | 25 | 28 |
| ROCE % | 9% | 15% | 30% | 33% | 28% | 21% | 20% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 15.42 | 14.12 | 14.59 | 13.16 | 10.04 |
| Diluted EPS (Rs.) | 15.42 | 14.12 | 14.59 | 13.16 | 10.04 |
| Cash EPS (Rs.) | 21.93 | 19.49 | 17.93 | 14.95 | 11.90 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 96.81 | 81.88 | 67.81 | 53.18 | 40.21 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 96.81 | 81.88 | 67.81 | 53.18 | 40.21 |
| Revenue From Operations / Share (Rs.) | 313.24 | 238.40 | 206.32 | 176.58 | 108.34 |
| PBDIT / Share (Rs.) | 32.70 | 27.52 | 26.63 | 22.04 | 18.27 |
| PBIT / Share (Rs.) | 26.19 | 22.15 | 23.30 | 20.25 | 16.42 |
| PBT / Share (Rs.) | 20.94 | 18.31 | 20.87 | 18.56 | 14.03 |
| Net Profit / Share (Rs.) | 15.41 | 14.13 | 14.59 | 13.16 | 10.04 |
| NP After MI And SOA / Share (Rs.) | 15.41 | 14.13 | 14.59 | 13.16 | 10.04 |
| PBDIT Margin (%) | 10.43 | 11.54 | 12.90 | 12.48 | 16.86 |
| PBIT Margin (%) | 8.36 | 9.29 | 11.29 | 11.46 | 15.15 |
| PBT Margin (%) | 6.68 | 7.68 | 10.11 | 10.50 | 12.95 |
| Net Profit Margin (%) | 4.92 | 5.92 | 7.07 | 7.45 | 9.27 |
| NP After MI And SOA Margin (%) | 4.92 | 5.92 | 7.07 | 7.45 | 9.27 |
| Return on Networth / Equity (%) | 15.92 | 17.25 | 21.51 | 24.75 | 24.97 |
| Return on Capital Employeed (%) | 20.80 | 19.94 | 26.46 | 31.05 | 32.01 |
| Return On Assets (%) | 7.30 | 7.18 | 9.70 | 11.13 | 12.83 |
| Long Term Debt / Equity (X) | 0.20 | 0.27 | 0.19 | 0.08 | 0.06 |
| Total Debt / Equity (X) | 0.43 | 0.44 | 0.37 | 0.33 | 0.26 |
| Asset Turnover Ratio (%) | 1.54 | 1.37 | 1.54 | 0.00 | 1.48 |
| Current Ratio (X) | 1.48 | 1.37 | 1.47 | 1.59 | 1.94 |
| Quick Ratio (X) | 1.27 | 1.04 | 1.22 | 1.30 | 1.65 |
| Inventory Turnover Ratio (X) | 9.85 | 7.98 | 9.77 | 0.00 | 9.59 |
| Interest Coverage Ratio (X) | 6.23 | 7.17 | 10.99 | 13.03 | 7.66 |
| Interest Coverage Ratio (Post Tax) (X) | 3.94 | 4.68 | 7.02 | 8.78 | 5.21 |
| Enterprise Value (Cr.) | 198.81 | 48.46 | 0.00 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 0.79 | 0.25 | 0.00 | 0.00 | 0.00 |
| EV / EBITDA (X) | 7.60 | 2.20 | 0.00 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 0.73 | 0.18 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 2.37 | 0.52 | 0.00 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 0.73 | 0.18 | 0.00 | 0.00 | 0.00 |
| EarningsYield | 0.06 | 0.32 | 0.00 | 0.00 | 0.00 |
After reviewing the key financial ratios for ARCL Organics Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 15.42. This value is within the healthy range. It has increased from 14.12 (Mar 24) to 15.42, marking an increase of 1.30.
- For Diluted EPS (Rs.), as of Mar 25, the value is 15.42. This value is within the healthy range. It has increased from 14.12 (Mar 24) to 15.42, marking an increase of 1.30.
- For Cash EPS (Rs.), as of Mar 25, the value is 21.93. This value is within the healthy range. It has increased from 19.49 (Mar 24) to 21.93, marking an increase of 2.44.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 96.81. It has increased from 81.88 (Mar 24) to 96.81, marking an increase of 14.93.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 96.81. It has increased from 81.88 (Mar 24) to 96.81, marking an increase of 14.93.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 313.24. It has increased from 238.40 (Mar 24) to 313.24, marking an increase of 74.84.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 32.70. This value is within the healthy range. It has increased from 27.52 (Mar 24) to 32.70, marking an increase of 5.18.
- For PBIT / Share (Rs.), as of Mar 25, the value is 26.19. This value is within the healthy range. It has increased from 22.15 (Mar 24) to 26.19, marking an increase of 4.04.
- For PBT / Share (Rs.), as of Mar 25, the value is 20.94. This value is within the healthy range. It has increased from 18.31 (Mar 24) to 20.94, marking an increase of 2.63.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 15.41. This value is within the healthy range. It has increased from 14.13 (Mar 24) to 15.41, marking an increase of 1.28.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 15.41. This value is within the healthy range. It has increased from 14.13 (Mar 24) to 15.41, marking an increase of 1.28.
- For PBDIT Margin (%), as of Mar 25, the value is 10.43. This value is within the healthy range. It has decreased from 11.54 (Mar 24) to 10.43, marking a decrease of 1.11.
- For PBIT Margin (%), as of Mar 25, the value is 8.36. This value is below the healthy minimum of 10. It has decreased from 9.29 (Mar 24) to 8.36, marking a decrease of 0.93.
- For PBT Margin (%), as of Mar 25, the value is 6.68. This value is below the healthy minimum of 10. It has decreased from 7.68 (Mar 24) to 6.68, marking a decrease of 1.00.
- For Net Profit Margin (%), as of Mar 25, the value is 4.92. This value is below the healthy minimum of 5. It has decreased from 5.92 (Mar 24) to 4.92, marking a decrease of 1.00.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.92. This value is below the healthy minimum of 8. It has decreased from 5.92 (Mar 24) to 4.92, marking a decrease of 1.00.
- For Return on Networth / Equity (%), as of Mar 25, the value is 15.92. This value is within the healthy range. It has decreased from 17.25 (Mar 24) to 15.92, marking a decrease of 1.33.
- For Return on Capital Employeed (%), as of Mar 25, the value is 20.80. This value is within the healthy range. It has increased from 19.94 (Mar 24) to 20.80, marking an increase of 0.86.
- For Return On Assets (%), as of Mar 25, the value is 7.30. This value is within the healthy range. It has increased from 7.18 (Mar 24) to 7.30, marking an increase of 0.12.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.20. This value is within the healthy range. It has decreased from 0.27 (Mar 24) to 0.20, marking a decrease of 0.07.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.43. This value is within the healthy range. It has decreased from 0.44 (Mar 24) to 0.43, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.54. It has increased from 1.37 (Mar 24) to 1.54, marking an increase of 0.17.
- For Current Ratio (X), as of Mar 25, the value is 1.48. This value is below the healthy minimum of 1.5. It has increased from 1.37 (Mar 24) to 1.48, marking an increase of 0.11.
- For Quick Ratio (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has increased from 1.04 (Mar 24) to 1.27, marking an increase of 0.23.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.85. This value exceeds the healthy maximum of 8. It has increased from 7.98 (Mar 24) to 9.85, marking an increase of 1.87.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.23. This value is within the healthy range. It has decreased from 7.17 (Mar 24) to 6.23, marking a decrease of 0.94.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.94. This value is within the healthy range. It has decreased from 4.68 (Mar 24) to 3.94, marking a decrease of 0.74.
- For Enterprise Value (Cr.), as of Mar 25, the value is 198.81. It has increased from 48.46 (Mar 24) to 198.81, marking an increase of 150.35.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 1. It has increased from 0.25 (Mar 24) to 0.79, marking an increase of 0.54.
- For EV / EBITDA (X), as of Mar 25, the value is 7.60. This value is within the healthy range. It has increased from 2.20 (Mar 24) to 7.60, marking an increase of 5.40.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 1. It has increased from 0.18 (Mar 24) to 0.73, marking an increase of 0.55.
- For Price / BV (X), as of Mar 25, the value is 2.37. This value is within the healthy range. It has increased from 0.52 (Mar 24) to 2.37, marking an increase of 1.85.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 1. It has increased from 0.18 (Mar 24) to 0.73, marking an increase of 0.55.
- For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has decreased from 0.32 (Mar 24) to 0.06, marking a decrease of 0.26.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in ARCL Organics Ltd:
- Net Profit Margin: 4.92%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 20.8% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 15.92% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.94
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.27
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 20.4 (Industry average Stock P/E: 402.5)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.43
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.92%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | Rampur, P.S. Maheshtala, Budge Budge Trunk Road, Kolkata West Bengal 700141 | legal@arcl.in http://www.arclorganics.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Suraj Ratan Mundhra | Chairman & Managing Director |
| Mr. Rajesh Mundhra | Executive Director |
| Mr. Brij Mohan Mohta | Ind. Non-Executive Director |
| Mrs. Stuti Pithisaria | Ind. Non-Executive Director |
| Mr. Prateek Chaudhary | Ind. Non-Executive Director |
| Mr. Mukesh Mundra | Executive Director |
FAQ
What is the intrinsic value of ARCL Organics Ltd?
ARCL Organics Ltd's intrinsic value (as of 06 November 2025) is 264.56 which is 19.83% lower the current market price of 330.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 264 Cr. market cap, FY2025-2026 high/low of 385/163, reserves of ₹68 Cr, and liabilities of 161 Cr.
What is the Market Cap of ARCL Organics Ltd?
The Market Cap of ARCL Organics Ltd is 264 Cr..
What is the current Stock Price of ARCL Organics Ltd as on 06 November 2025?
The current stock price of ARCL Organics Ltd as on 06 November 2025 is 330.
What is the High / Low of ARCL Organics Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of ARCL Organics Ltd stocks is 385/163.
What is the Stock P/E of ARCL Organics Ltd?
The Stock P/E of ARCL Organics Ltd is 20.4.
What is the Book Value of ARCL Organics Ltd?
The Book Value of ARCL Organics Ltd is 94.6.
What is the Dividend Yield of ARCL Organics Ltd?
The Dividend Yield of ARCL Organics Ltd is 0.00 %.
What is the ROCE of ARCL Organics Ltd?
The ROCE of ARCL Organics Ltd is 20.4 %.
What is the ROE of ARCL Organics Ltd?
The ROE of ARCL Organics Ltd is 16.8 %.
What is the Face Value of ARCL Organics Ltd?
The Face Value of ARCL Organics Ltd is 10.0.